MDM2 and cancer: For example, previous studies have demonstrated that p52-ZER6 facilitates p53 ubiquitination and proteasomal degradation by promoting and stabilizing the formation of the p53/MDM2 complex, thereby acting as a driving factor in cancer development [124].